{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:51:01Z","timestamp":1791924661370,"version":"4.3.4"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,25]],"date-time":"2024-12-25T00:00:00Z","timestamp":1735084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.lfs.2024.123338","type":"journal-article","created":{"date-parts":[[2024,12,25]],"date-time":"2024-12-25T15:55:47Z","timestamp":1735142147000},"page":"123338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Insight into a multifunctional potassium channel Kv1.3 and its novel implication in chronic kidney disease"],"prefix":"10.1016","volume":"362","author":[{"given":"Zac","family":"Dragan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol A.","family":"Pollock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunling","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2024.123338_bb0005","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/9609266","article-title":"The growing challenge of chronic kidney disease: an overview of current knowledge","volume":"2023","author":"Borg","year":"2023","journal-title":"Int. J. Nephrol."},{"key":"10.1016\/j.lfs.2024.123338_bb0010","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/ckj\/sfac218","article-title":"Temporal trends in prevalence and mortality for chronic kidney disease in China from 1990 to 2019: an analysis of the global burden of disease study 2019","volume":"16","author":"Li","year":"2023","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.lfs.2024.123338_bb0015","doi-asserted-by":"crossref","first-page":"52","DOI":"10.33594\/000000195","article-title":"Mitochondrial Kv1.3: a new target in cancer biology?","volume":"53","author":"Checchetto","year":"2019","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.lfs.2024.123338_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2022.100146","article-title":"Pharmacological blockade of KV1.3 channel as a promising treatment in autoimmune diseases","volume":"5","author":"Canas","year":"2022","journal-title":"J. Transl. Autoimmun."},{"key":"10.1016\/j.lfs.2024.123338_bb0025","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.3389\/fnins.2019.01393","article-title":"Kv1.3 channel as a key therapeutic target for neuroinflammatory diseases: state of the art and beyond","volume":"13","author":"Wang","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.lfs.2024.123338_bb0030","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/j.1365-2826.2012.02314.x","article-title":"Diet-induced obesity resistance of Kv1.3-\/- mice is olfactory bulb dependent","volume":"24","author":"Tucker","year":"2012","journal-title":"J. Neuroendocrinol."},{"issue":"2","key":"10.1016\/j.lfs.2024.123338_bb0035","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/ejp.2059","article-title":"Spinal voltage-gated potassium channel Kv1.3 contributes to neuropathic pain via the promotion of microglial M1 polarization and activation of the NLRP3 inflammasome","volume":"27","author":"Yuan","year":"2023","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.lfs.2024.123338_bb0040","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1002\/acn3.51456","article-title":"The potassium channel Kv1.3 as a therapeutic target for immunocytoprotection after reperfusion","volume":"8","author":"Chen","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.lfs.2024.123338_bb0045","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1002\/med.21800","article-title":"Discovery of K(V) 1.3 ion channel inhibitors: medicinal chemistry approaches and challenges","volume":"41","author":"Gubic","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.lfs.2024.123338_bb0050","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/307468a0","article-title":"K channels in T lymphocytes: a patch clamp study using monoclonal antibody adhesion","volume":"307","author":"Matteson","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2024.123338_bb0055","doi-asserted-by":"crossref","first-page":"C27","DOI":"10.1152\/ajpcell.00136.2017","article-title":"The secret life of ion channels: Kv1.3 potassium channels and proliferation","volume":"314","author":"Perez-Garcia","year":"2018","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.lfs.2024.123338_bb0060","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1038\/s41467-022-31285-5","article-title":"Structures of the T cell potassium channel Kv1.3 with immunoglobulin modulators","volume":"13","author":"Selvakumar","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2024.123338_bb0065","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2113536119","article-title":"Rearrangement of a unique Kv1.3 selectivity filter conformation upon binding of a drug","volume":"119","author":"Tyagi","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2024.123338_bb0070","first-page":"515","article-title":"Biophysical and pharmacological aspects of K+ channels in T lymphocytes","volume":"34","author":"Panyi","year":"2005","journal-title":"Eur. Biophys. J."},{"key":"10.1016\/j.lfs.2024.123338_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15102716","article-title":"The phosphorylation of Kv1.3: a modulatory mechanism for a multifunctional ion channel","volume":"15","author":"Navarro-Perez","year":"2023","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.lfs.2024.123338_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13174457","article-title":"Kv1.3 controls mitochondrial dynamics during cell cycle progression","volume":"13","author":"Capera","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.lfs.2024.123338_bb0085","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.3390\/ijms24021311","article-title":"Flavonoids as modulators of potassium channels","volume":"24","author":"Richter-Laskowska","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.123338_bb0090","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3389\/fonc.2019.00933","article-title":"Voltage-gated potassium channel Kv1.3 as a target in therapy of cancer","volume":"9","author":"Teisseyre","year":"2019","journal-title":"Front. Oncol."},{"issue":"15","key":"10.1016\/j.lfs.2024.123338_bb0095","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.3390\/cancers14153564","article-title":"How the potassium channel response of T lymphocytes to the tumor microenvironment shapes antitumor immunity","volume":"14","author":"Chirra","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.lfs.2024.123338_bb0100","doi-asserted-by":"crossref","first-page":"145","DOI":"10.33594\/000000375","article-title":"Impact of diverse ion channels on regulatory T cell functions","volume":"55","author":"Vinnenberg","year":"2021","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.lfs.2024.123338_bb0105","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1002\/glia.23847","article-title":"Biophysical basis for Kv1.3 regulation of membrane potential changes induced by P2X4-mediated calcium entry in microglia","volume":"68","author":"Nguyen","year":"2020","journal-title":"Glia"},{"key":"10.1016\/j.lfs.2024.123338_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040913","article-title":"Contribution of the potassium channels K(V)1.3 and K(ca)3.1 to smooth muscle cell proliferation in growing collateral arteries","volume":"9","author":"Lasch","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.lfs.2024.123338_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.153113","article-title":"The cajanine derivative LJ101019C regulates the proliferation and enhances the activity of NK cells via Kv1.3 channel-driven activation of the AKT\/mTOR pathway","volume":"66","author":"Geng","year":"2020","journal-title":"Phytomedicine"},{"key":"10.1016\/j.lfs.2024.123338_bb0120","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s41419-021-03627-6","article-title":"Kv1.3 voltage-gated potassium channels link cellular respiration to proliferation through a non-conducting mechanism","volume":"12","author":"Styles","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2024.123338_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116368","article-title":"KCNE4-dependent modulation of Kv1.3 pharmacology","volume":"226","author":"Sastre","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2024.123338_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.33594\/000000187","article-title":"Inhibition of PI-3-K and AKT amplifies Kv1.3 inhibitor-induced death of human T leukemia cells","volume":"53","author":"Bergermann","year":"2019","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.lfs.2024.123338_bb0135","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1177\/2472555219864894","article-title":"Targeting the mitochondrial potassium channel Kv1.3 to kill cancer cells: drugs, strategies, and new perspectives","volume":"24","author":"Prosdocimi","year":"2019","journal-title":"SLAS Discov."},{"key":"10.1016\/j.lfs.2024.123338_bb0140","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ccell.2017.03.003","article-title":"Direct pharmacological targeting of a mitochondrial ion channel selectively kills tumor cells in vivo","volume":"31","author":"Leanza","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.lfs.2024.123338_bb0145","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13046-022-02249-w","article-title":"Pharmacological modulation of Kv1.3 potassium channel selectively triggers pathological B lymphocyte apoptosis in vivo in a genetic CLL model","volume":"41","author":"Severin","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2024.123338_bb0150","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.69099","article-title":"A novel mitochondrial Kv1.3-caveolin axis controls cell survival and apoptosis","volume":"10","author":"Capera","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.lfs.2024.123338_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.865686","article-title":"The mitochondrial routing of the Kv1.3 channel","volume":"12","author":"Capera","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lfs.2024.123338_bb0160","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1111\/jnc.15200","article-title":"Olfactory bulb-targeted quantum dot (QD) bioconjugate and Kv1.3 blocking peptide improve metabolic health in obese male mice","volume":"157","author":"Schwartz","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.lfs.2024.123338_bb0165","doi-asserted-by":"crossref","first-page":"5966","DOI":"10.1523\/JNEUROSCI.0190-22.2022","article-title":"Modulating the excitability of olfactory output neurons affects whole-body metabolism","volume":"42","author":"Kolling","year":"2022","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.lfs.2024.123338_bb0170","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10557-021-07264-1","article-title":"Kv1.3 channel blockade improves inflammatory profile, reduces cardiac electrical remodeling, and prevents arrhythmia in type 2 diabetic rats","volume":"37","author":"Zayas-Arrabal","year":"2023","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.lfs.2024.123338_bb0175","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14254","article-title":"Long-term obesogenic diet and targeted deletion of potassium channel K(v) 1.3 have differing effects on voluntary exercise in mice","volume":"7","author":"Chelette","year":"2019","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.lfs.2024.123338_bb0180","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00429-018-1776-0","article-title":"Modulation of olfactory-driven behavior by metabolic signals: role of the piriform cortex","volume":"224","author":"Al Koborssy","year":"2019","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.lfs.2024.123338_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/nu14234986","article-title":"Olfactory sensitivity is associated with body mass index and polymorphism in the voltage-gated potassium channels Kv1.3","volume":"14","author":"Melis","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.lfs.2024.123338_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102468","article-title":"Potassium ions promote hexokinase-II dependent glycolysis","volume":"24","author":"Bischof","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.lfs.2024.123338_bb0195","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.2337\/db17-1223","article-title":"Whole-organism chemical screening identifies modulators of pancreatic \u03b2-cell function","volume":"67","author":"Matsuda","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2024.123338_bb0200","article-title":"Different functional roles for K(+) channel subtypes in regulating small intestinal glucose and ion transport","volume":"8","author":"Du","year":"2019","journal-title":"Biol. Open."},{"key":"10.1016\/j.lfs.2024.123338_bb0205","article-title":"Kv1.3 K(+) channel physiology assessed by genetic and pharmacological modulation","volume":"38","author":"Varanita","year":"2023","journal-title":"Physiology (Bethesda)"},{"key":"10.1016\/j.lfs.2024.123338_bb0210","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1007\/s00018-018-2851-7","article-title":"Caveolar targeting links Kv1.3 with the insulin-dependent adipocyte physiology","volume":"75","author":"P\u00e9rez-Verdaguer","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"issue":"4","key":"10.1016\/j.lfs.2024.123338_bb0215","doi-asserted-by":"crossref","first-page":"671","DOI":"10.7150\/ijbs.38950","article-title":"Blockage of Kv1.3 regulates macrophage migration in acute liver injury by targeting delta-catenin through RhoA signaling","volume":"16","author":"Wu","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.lfs.2024.123338_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22042081","article-title":"Potassium channels Kv1.3 and Kir2.1 but not Kv1.5 contribute to BV2 cell line and primary microglial migration","volume":"22","author":"Anton","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.123338_bb0225","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fphar.2020.00101","article-title":"Pleiotropic effects of simvastatin on the regulation of potassium channels in monocytes","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2024.123338_bb0230","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/cvr\/cvab133","article-title":"The voltage-gated potassium channel KV1.3 regulates neutrophil recruitment during inflammation","volume":"118","author":"Immler","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.lfs.2024.123338_bb0235","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/09537104.2021.1942818","article-title":"The voltage-gated K(+) channel Kv1.3 modulates platelet motility and \u03b1(2)\u03b2(1) integrin-dependent adhesion to collagen","volume":"33","author":"Wright","year":"2022","journal-title":"Platelets"},{"key":"10.1016\/j.lfs.2024.123338_bb0240","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1161\/ATVBAHA.120.314278","article-title":"Role of Kv1.3 channels in platelet functions and thrombus formation","volume":"40","author":"Fan","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.lfs.2024.123338_bb0245","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.toxicon.2021.03.002","article-title":"Lipopolysaccharide influences the plasma and brain pharmacokinetics of subcutaneously-administered HsTX1[R14A], a KV1.3-blocking peptide","volume":"195","author":"Reddiar","year":"2021","journal-title":"Toxicon"},{"key":"10.1016\/j.lfs.2024.123338_bb0250","doi-asserted-by":"crossref","DOI":"10.1007\/s13311-023-01387-z","article-title":"Peripheral administration of the Kv1.3-blocking peptide HsTX1[R14A] improves cognitive performance in senescence accelerated SAMP8 mice","author":"Pan","year":"2023","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.lfs.2024.123338_bb0255","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.xphs.2021.11.003","article-title":"Blockade of microglial Kv1.3 potassium channels by the peptide HsTX1[R14A] attenuates lipopolysaccharide-mediated neuroinflammation","volume":"111","author":"Nicolazzo","year":"2022","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.lfs.2024.123338_bb0260","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1021\/acs.bioconjchem.2c00436","article-title":"A fluorescent peptide toxin for selective visualization of the voltage-gated potassium channel K(V)1.3","volume":"33","author":"Wai","year":"2022","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.lfs.2024.123338_bb0265","first-page":"103","article-title":"Margatoxin mitigates CCl4-induced hepatic fibrosis in mice via macrophage polarization, cytokine secretion and STAT signaling","volume":"45","author":"Wu","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.lfs.2024.123338_bb0270","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.733610","article-title":"Optimization of Pichia pastoris expression system for high-level production of margatoxin","volume":"12","author":"Naseem","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2024.123338_bb0275","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031724","article-title":"GFP-margatoxin, a genetically encoded fluorescent ligand to probe affinity of Kv1.3 channel blockers","volume":"23","author":"Denisova","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.123338_bb0280","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijbiomac.2021.02.155","article-title":"Different pharmacological properties between scorpion toxin BmKcug2 and its degraded analogs highlight the diversity of K(+) channel blockers from thermally processed scorpions","volume":"178","author":"Qin","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.lfs.2024.123338_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116624","article-title":"BmKK2, a thermostable Kv1.3 blocker from Buthus martensii Karsch (BmK) scorpion, inhibits the activation of macrophages via Kv1.3-NF-kappaB- NLRP3 axis","volume":"314","author":"Wang","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.lfs.2024.123338_bb0290","doi-asserted-by":"crossref","DOI":"10.3390\/toxins15050340","article-title":"Functional characterization of a new degradation peptide BmTX4-P1 from traditional Chinese scorpion medicinal material","volume":"15","author":"Qin","year":"2023","journal-title":"Toxins (Basel)."},{"key":"10.1016\/j.lfs.2024.123338_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113782","article-title":"Structural basis of the potency and selectivity of Urotoxin, a potent Kv1 blocker from scorpion venom","volume":"174","author":"Luna-Ramirez","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2024.123338_bb0300","doi-asserted-by":"crossref","DOI":"10.1085\/jgp.202213146","article-title":"Cm28, a scorpion toxin having a unique primary structure, inhibits KV1.2 and KV1.3 with high affinity","volume":"154","author":"Naseem","year":"2022","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.lfs.2024.123338_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115023","article-title":"Panyi, sVmKTx, a transcriptome analysis-based synthetic peptide analogue of Vm24, inhibits Kv1.3 channels of human T cells with improved selectivity","volume":"199","author":"Csoti","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2024.123338_bb0310","article-title":"Atto488-agitoxin 2-A fluorescent ligand with increased selectivity for Kv1.3 channel binding site","volume":"9","author":"Denisova","year":"2022","journal-title":"Bioengineering (Basel)."},{"key":"10.1016\/j.lfs.2024.123338_bb0315","doi-asserted-by":"crossref","DOI":"10.3390\/toxins15030229","article-title":"AgTx2-GFP, fluorescent blocker targeting pharmacologically important K(v)1.x (x = 1, 3, 6) channels","volume":"15","author":"Primak","year":"2023","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.lfs.2024.123338_bb0320","doi-asserted-by":"crossref","first-page":"15492","DOI":"10.1096\/fj.202000861RR","article-title":"Blockade of Kv1.3 potassium channel inhibits CD8(+) T cell-mediated neuroinflammation via PD-1\/Blimp-1 signaling","volume":"34","author":"Zhao","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.lfs.2024.123338_bb0325","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1124\/molpharm.121.000480","article-title":"Mechanisms underlying the inhibition of KV1.3 channel by scorpion toxin ImKTX58","volume":"102","author":"Zhang","year":"2022","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.lfs.2024.123338_bb0330","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1124\/mol.105.015669","article-title":"Design of PAP-1, a selective small molecule Kv1.3 blocker, for the suppression of effector memory T cells in autoimmune diseases","volume":"68","author":"Schmitz","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.lfs.2024.123338_bb0335","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.trsl.2020.06.002","article-title":"Kv1.3 blockade inhibits proliferation of vascular smooth muscle cells in vitro and intimal hyperplasia in vivo","volume":"224","author":"Bobi","year":"2020","journal-title":"Transl. Res."},{"key":"10.1016\/j.lfs.2024.123338_bb0340","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.actbio.2020.07.053","article-title":"Elastin-like recombinamer-based devices releasing Kv1.3 blockers for the prevention of intimal hyperplasia: an in vitro and in vivo study","volume":"115","author":"Moreno-Estar","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.lfs.2024.123338_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101705","article-title":"Insight into the mechanism of cytotoxicity of membrane-permeant psoralenic Kv1.3 channel inhibitors by chemical dissection of a novel member of the family","volume":"37","author":"Peruzzo","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.lfs.2024.123338_bb0350","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1190476","article-title":"Immunocytoprotection after reperfusion with Kv1.3 inhibitors has an extended treatment window for ischemic stroke","volume":"14","author":"Lee","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2024.123338_bb0355","article-title":"Blockade of Kv1.3 potassium channel inhibits microglia-mediated neuroinflammation in epilepsy","volume":"23","author":"Zhang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.lfs.2024.123338_bb0360","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14081955","article-title":"Mitochondrial Kv1.3 channels as target for treatment of multiple myeloma","volume":"14","author":"Kadow","year":"2022","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.lfs.2024.123338_bb0365","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.3390\/cancers14112618","article-title":"Inhibition of a mitochondrial potassium channel in combination with gemcitabine and abraxane drastically reduces pancreatic ductal adenocarcinoma in an immunocompetent orthotopic murine model","volume":"14","author":"Li","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.lfs.2024.123338_bb0370","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.bbrc.2020.08.050","article-title":"Methotrexate, a small molecular scaffold targeting Kv1.3 channel extracellular pore region","volume":"532","author":"Xie","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2024.123338_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174567","article-title":"Inhibitory effect of the selective serotonin reuptake inhibitor paroxetine on human Kv1.3 channels","volume":"912","author":"Hwang","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2024.123338_bb0380","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1143350","article-title":"Immune and ionic mechanisms mediating the effect of dexamethasone in severe COVID-19","volume":"14","author":"Chimote","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2024.123338_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103746","article-title":"Design and characterization of a novel structural class of Kv1.3 inhibitors","volume":"98","author":"Hendrickx","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"11","key":"10.1016\/j.lfs.2024.123338_bb0390","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.3390\/cancers14112595","article-title":"Design of new potent and selective thiophene-based Kv1.3 inhibitors and their potential for anticancer activity","volume":"14","author":"Gubic","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.lfs.2024.123338_bb0395","article-title":"Inhibitory effects of 2-aminoethoxydiphenyl borate (2-APB) on three K(V)1 channel currents","volume":"28","author":"Zhao","year":"2023","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.lfs.2024.123338_bb0400","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1021\/acsptsci.0c00035","article-title":"Modulation of lymphocyte potassium channel KV1.3 by membrane-penetrating, joint-targeting immunomodulatory plant defensin","volume":"3","author":"Ong","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.lfs.2024.123338_bb0405","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1111\/bph.15441","article-title":"Identification of WP1066, an inhibitor of JAK2 and STAT3, as a K(V) 1.3 potassium channel blocker","volume":"178","author":"Li","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2024.123338_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175242","article-title":"Bergapten attenuates microglia-mediated neuroinflammation and ischemic brain injury by targeting Kv1.3 and carbonyl reductase 1","volume":"933","author":"Gao","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2024.123338_bb0415","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1021\/acs.jnatprod.1c00879","article-title":"Jatrophane diterpenoids with Kv1.3 ion channel inhibitory effects from Euphorbia helioscopia","volume":"85","author":"Zhou","year":"2022","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.lfs.2024.123338_bb0420","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1094649","article-title":"The immunosuppressive effects and mechanisms of loureirin B on collagen-induced arthritis in rats","volume":"14","author":"Zou","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2024.123338_bb0425","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27103227","article-title":"Co-application of statin and flavonoids as an effective strategy to reduce the activity of voltage-gated potassium channels Kv1.3 and induce apoptosis in human leukemic T cell line Jurkat","volume":"27","author":"Teisseyre","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.lfs.2024.123338_bb0430","doi-asserted-by":"crossref","DOI":"10.3390\/md18080425","article-title":"Studies of conorfamide-Sr3 on human voltage-gated Kv1 potassium channel subtypes","volume":"18","author":"L\u00f3pez-Vera","year":"2020","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.lfs.2024.123338_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100670","article-title":"Anti-inflammatory effects of FS48, the first potassium channel inhibitor from the salivary glands of the flea Xenopsylla cheopis","volume":"296","author":"Deng","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2024.123338_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101497","article-title":"The toxin mimic FS48 from the salivary gland of Xenopsylla cheopis functions as a Kv1.3 channel-blocking immunomodulator of T cell activation","volume":"298","author":"Zeng","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2024.123338_bb0445","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2478\/acph-2023-0010","article-title":"The in vitro anticancer effects of FS48 from salivary glands of Xenopsylla cheopis on NCI-H460 cells via its blockage of voltage-gated K+channels","volume":"73","author":"Xiong","year":"2023","journal-title":"Acta Pharm."},{"key":"10.1016\/j.lfs.2024.123338_bb0450","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00109-021-02140-9","article-title":"Synthetic polypeptide crotamine: characterization as a myotoxin and as a target of combinatorial peptides","volume":"100","author":"Pompeia","year":"2022","journal-title":"J. Mol. Med. (Berl)"},{"issue":"2","key":"10.1016\/j.lfs.2024.123338_bb0455","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3390\/md20020147","article-title":"A tale of toxin promiscuity: the versatile pharmacological effects of Hcr 1b-2 sea anemone peptide on voltage-gated ion channels","volume":"20","author":"Pinheiro-Junior","year":"2022","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.lfs.2024.123338_bb0460","article-title":"Kv1.3 blockade by ShK186 modulates CD4+ effector memory T-cell activity of patients with Granulomatosis with polyangiitis","author":"Lintermans","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lfs.2024.123338_bb0465","article-title":"A bioengineered probiotic for the oral delivery of a peptide Kv1.3 channel blocker to treat rheumatoid arthritis","volume":"120","author":"Wang","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2024.123338_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116651","article-title":"Voltage-gated potassium channel 1.3: a promising molecular target in multiple disease therapy","volume":"175","author":"Cheng","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.lfs.2024.123338_bb0475","doi-asserted-by":"crossref","first-page":"F1258","DOI":"10.1152\/ajprenal.00374.2010","article-title":"Voltage-gated potassium channel Kv1.3 blocker as a potential treatment for rat anti-glomerular basement membrane glomerulonephritis","volume":"299","author":"Hyodo","year":"2010","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.lfs.2024.123338_bb0480","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd1471","article-title":"Targeted knockdown of Kv1.3 channels in T lymphocytes corrects the disease manifestations associated with systemic lupus erythematosus","volume":"6","author":"Khodoun","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.lfs.2024.123338_bb0485","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/581581","article-title":"Overexpression of delayed rectifier K(+) channels promotes in situ proliferation of leukocytes in rat kidneys with advanced chronic renal failure","volume":"2012","author":"Kazama","year":"2012","journal-title":"Int. J. Nephrol."},{"key":"10.1016\/j.lfs.2024.123338_bb0490","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000368080","article-title":"Benidipine suppresses in situ proliferation of leukocytes and slows the progression of renal fibrosis in rat kidneys with advanced chronic renal failure","volume":"128","author":"Kazama","year":"2014","journal-title":"Nephron Exp. Nephrol."},{"key":"10.1016\/j.lfs.2024.123338_bb0495","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7567638","article-title":"Delayed rectifier K(+)-channel is a novel therapeutic target for interstitial renal fibrosis in rats with unilateral ureteral obstruction","volume":"2019","author":"Abe","year":"2019","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.lfs.2024.123338_bb0500","article-title":"Kv1.3 channel inhibition limits uremia-induced calcification in mouse and human vascular smooth muscle","volume":"2","author":"Caza\u00f1a-P\u00e9rez","year":"2021","journal-title":"Function (Oxf)."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524009287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524009287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T02:22:10Z","timestamp":1736994130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320524009287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":100,"alternative-id":["S0024320524009287"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2024.123338","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insight into a multifunctional potassium channel Kv1.3 and its novel implication in chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2024.123338","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"123338"}}